That's an important question to ask, especially when managing leukemia treatment. Pegasys (pegylated interferon alfa-2a) is used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL).
Pegasys can potentially cause liver-related side effects, including hepatotoxicity Show Full Answer
That's an important question to ask, especially when managing leukemia treatment. Pegasys (pegylated interferon alfa-2a) is used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL).
Pegasys can potentially cause liver-related side effects, including hepatotoxicity (liver damage). This is a known risk with interferon-based therapies. Here are some important points to keep in mind:
- Liver function monitoring is typically recommended regularly while on Pegasys, as the drug can elevate liver enzymes
- The 135 mcg dose is a lower pegylated formulation, designed to stay in the blood longer and reduce side effects compared to older interferon versions
- Signs of liver issues to watch for include yellowing of the skin or eyes (jaundice), dark urine, severe fatigue, or upper right abdominal pain
- Dose adjustments or stopping treatment may be necessary if liver enzyme levels become too elevated
It's really important to discuss any concerns about liver function with your oncologist, who can monitor your levels through regular blood tests and adjust your treatment if needed.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Interferon Therapy for Leukemia: When Is It Used?
May 3
Join
Your Privacy Choices
